TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Cytokinetics Inc (CYTK)

Healthcare Biotechnology
76.50 $
-0.9% vs. previous close
Closing price · As of: 3. Aug 2026

Cytokinetics Inc (CYTK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 1,273 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Balance Sheet CYTK
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
780 741 824 808 1,524 1,436 1,402 1,264 1,226 1,437 1,425 1,273
587 561 628 639 1,068 1,019 1,108 956 887 977 917 839
69 100 113 120 191 47 95 74 75 225 123 130
566 539 615 619 1,057 1,012 1,076 938 858 963 882 819
1.0 2.5 1.3 0.8 0.0 0.2 17 2.0 8.4 1.8 18 6.8
-1.0 -2.5 -0.8 -0.2 0.2
158
1,113 1,179 1,211 1,204 1,415 1,450 1,537 1,530 1,594 1,958 2,084 2,100
66 78 103 89 103 110 180 160 131 142 202 199
16 17 28 30 30 30 30 33 34 38 60 66
13 14 22 13 9.5 12 20 14 16 22 22 25
610 609 607 607 643 644 646 645 713 1,048 1,116 1,118
-333 -439 -386 -396 109 -14 -135 -266 -369 -521 -660 -827
-1,846 -1,975 -2,112 -2,248 -2,391 -2,552 -2,702 -2,863 -2,998 -3,304 -3,487 -3,693
96 96 99 102 109 118 118 118 119 120 122 123

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?